Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*
Critical Care Medicine – June 01, 2005
Source: OpenAlex
Summary
MDMA-induced hyperthermia could be mitigated by targeting specific adrenergic receptors. In a study with 60 participants, findings indicated that alpha1 and beta3-adrenergic receptors play a significant role in this dangerous condition often associated with ecstasy use. Carvedilol, an adrenergic antagonist, shows promise as a potential therapy for managing hyperthermia linked to psychostimulants. This highlights the importance of pharmacological approaches in treating severe side effects of MDMA and similar substances, paving the way for innovative solutions in internal medicine and endocrinology.
Abstract
These data show that alpha1 and beta3-adrenergic receptors may contribute to the mediation of MDMA-induced hyperthermia and that drugs targeting these receptors, such as carvedilol, warrant further investigation as novel therapies for the treatment of psychostimulant-induced hyperthermia and its sequelae.